Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05321602
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:53.717054+00:00
Published At
2024-03-19T00:00:00+00:00
Record Updated At
2024-03-19
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Schizophrenia", "Psychotic Disorders", "Mood Disorders", "Schizophrenia Spectrum and Other Psychotic Disorders", "Mental Disorders", "Antipsychotic Agents", "Tranquilizing Agents", "Central Nervous System Depression", "Physiological Effects of Drugs", "Psychotropic Drugs", "Neurotransmitter Agents", "Molecular Mechanisms of Pharmacological Action"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-03-19"
protocolSection.identificationModule.nctId
"NCT05321602"
protocolSection.identificationModule.officialTitle
"A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Schizophrenia (protocolSection.conditionsModule.conditions)
  • Psychotic Disorders (protocolSection.conditionsModule.conditions)
  • Mood Disorders (protocolSection.conditionsModule.conditions)
  • Schizophrenia Spectrum and Other Psychotic Disorders (protocolSection.conditionsModule.conditions)
  • Mental Disorders (protocolSection.conditionsModule.conditions)
  • Antipsychotic Agents (protocolSection.conditionsModule.conditions)
  • Tranquilizing Agents (protocolSection.conditionsModule.conditions)
  • Central Nervous System Depression (protocolSection.conditionsModule.conditions)
  • Physiological Effects of Drugs (protocolSection.conditionsModule.conditions)
  • Psychotropic Drugs (protocolSection.conditionsModule.conditions)
  • Neurotransmitter Agents (protocolSection.conditionsModule.conditions)
  • Molecular Mechanisms of Pharmacological Action (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.